fda compounding semaglutide crackdown november 2025 How Crackdowns Are Affecting GLP-1 Use In Compounded Semaglutide: Safety & Regulation

Clinical studies reveal a nuanced picture: the SUSTAIN-6 trial involving over 3,000 patients found that semaglutide users experienced modest reductions in systolic blood pressure over time, largely attributed to weight loss rather than the drug directly lowering pressure

Setmelanotide can bypass upstream defects but cannot repair the receptor itself

Hypoglycemia In the above studies (N=9), adverse reactions of hypoglycemia were based on all reports of symptomatic hypoglycemia

Aim for 1.62.2g of protein per kg of bodyweight daily

Slower digestion: Using alcohol and GLP-1 together can lead to more bloating or belly discomfort

For moderate hyperkalemia, urinary K excretion should be increased by administration of diuretics, such as furosemide, and sodium bicarbonate in individuals with metabolic acidosis